Search Results 901-910 of 18594 for Relapse
"But most of those patients relapsed within two years, as the CAR-T cells ... Kenderian's, was designed to address relapse. Previous clinical trials ...
... relapsed Acute myelogenous leukemia (AML) and other selected B-cell ... First Relapse and primary induction failure in AML (M3 excluded); Secondary ...
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies ... relapse, and subsequent therapy. A Study of Nab-Paclitaxel as ...
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies ... relapse, and subsequent therapy. Effect of Agent Orange ...
Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma featured. Cancer. Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin ...
... Relapsed or Refractory NHL. The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or ...
... relapse based on the presence of pre-transplant risk factors. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Cancer. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.